Blocking RAS/MEK/PI3K Boosts CD40 Therapy in Melanoma
In a groundbreaking advancement addressing one of the most formidable challenges in oncology, recent research has unveiled a novel therapeutic ...
In a groundbreaking advancement addressing one of the most formidable challenges in oncology, recent research has unveiled a novel therapeutic ...
In a groundbreaking study published in the Journal of Translational Medicine, a team of researchers has illuminated a critical pathway ...
Liver cancer stands as one of the most formidable challenges in modern oncology, with hepatocellular carcinoma (HCC) representing the dominant ...
In a groundbreaking advancement in oncology, a recent Phase I clinical trial has explored the therapeutic potential of tifcemalimab, both ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine